BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Neulasta®: Possibility of counterfeits being on the market

2015.03.06

Active substance: pegfilgrastim

The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) has received information via the "Land" authority ("Landesbehörde") of Bavaria and via the EU's Rapid Alert System (RAS) that counterfeits of the medicinal product Neulasta® have possibly reached Germany.

risk information - full text (available in German only)